【レポートの概要（一部）】
1. Report Overview
1.1 Global Drug Delivery Technologies Market Overview
1.2 Global Drug Delivery Technologies Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction to Drug Delivery
2.1 Drug Delivery Technologies (DDT)
2.2 Drug Delivery Technologies – Types
2.2.1 Injection As a Route of Drug Delivery
2.2.2 Needle-free Transdermal Delivery
2.2.3 Oral Delivery Technologies
2.2.4 Inhalation or Spray
2.3 Sustained/Controlled Release Systems
2.4 Biopharmaceuticals
2.4.1 An introduction to the Biologic Drugs Market
2.4.2 Biologics: A Rising Drugs Market
2.4.3 Biotech Drugs with Associated Drug Delivery Technologies
2.4.4 Pegylated Interferons
2.4.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
2.4.6 The Main Challenges Facing Biological Drug Delivery
2.5 Market Definition
3. The Global Drug Delivery Technologies Market, 2014-2024
3.1 Global Drug Delivery Technologies: Market Overview
3.1.1 Drug Delivery Technologies: A Growing Market
3.2 The Global Drug Delivery Technologies Market in 2013
3.2.1 Global Drug Delivery Technologies: Market Forecast 2014-2024
3.2.2 Changing Market Shares by Sector 2014-2024
3.3 Oral Drug Delivery Technologies Market 2014-2024
3.3.1 Oral Drug Delivery Technologies: Market Forecast 2014-2024
3.4 Inhalation Drug Delivery Technologies Market 2014-2024
3.4.1 Inhalation Drug Delivery Technologies: Market Forecast 2014-2024
3.5 Injectable/Implants Drug Delivery Technologies Market 2014-2024
3.5.1 Injectable/Implants Drug Delivery Technologies: Market Forecast 2014-2024
3.6 Transdermal Drug Delivery Technologies Market 2014-2024
3.6.1 Transdermal Drug Delivery Technologies: Market Forecast 2014-2024
3.7 Ocular Drug Delivery Technologies Market 2014-2024
3.7.1 Ocular Drug Delivery Technologies: Market Forecast 2014-2024
3.8 Nasal Drug Delivery Technologies Market 2014-2024
3.8.1 Nasal Drug Delivery Technologies: Market Forecast 2014-2024
4. Leading National Markets 2014-2024
4.1 The Drug Delivery Technologies Market by Regional Revenue
4.1.1 The Global Distribution of Drug Delivery Technologies in 2013
4.2 Leading National Markets: Forecast, 2014-2024
4.2.1 Changing Market Shares by Region, 2014-2024
4.3 Regional Drug Delivery Technologies Markets: Analysis and Forecasts, 2014-2024
4.3.1 United States: The Largest Market for Drug Delivery Technologies
4.3.2 The EU5 Markets:
4.3.2.1 EU5: Changing Market Shares by Country, 2014-2024
4.3.2.2 Germany: Fiscal Austerity Programs and Spending Cuts
4.3.2.3 France: Strong Drug Discovery Landscape
4.3.2.4 UK: An Increasingly Service-Oriented Market
4.3.2.5 Spain: Recovering Economy to Stimulate Healthcare Investment
4.3.2.6 Italy: Changing Reimbursement Culture Will Aid Market Growth
4.3.3 Japan: Aging Population Stimulating Drug Demand
4.3.4 China: Intensive Talent Resource and Relative Low Cost
4.3.5 India: A Hotbed For Drug Delivery Technology Manufacturing and Outsourcing
4.3.6 Brazil: Government Subsidies Boosting Drug Production
4.3.7 Russia: Availability of Custom Libraries for Drug Molecules Will Catalyse Growth
4.3.8 South Korea: Acquisition of Promising Overseas Companies Will Aid Market Growth
4.3.9 Mexico: Government Initiatives and Regulatory Changes Boosting Market Growth
4.3.10 Rest of the World
5. Leading Drug Classes Offering Growth for Drug Delivery Technologies
5.1 Therapeutic Areas Offering Growth Opportunities
5.2 Biologics: A Future Driver for Growth in Drug Delivery Technologies
5.2.1 Leading Classes of Biological Drugs, 2013
5.3 Monoclonal Antibodies: Largest Sector in Biologics
5.3.1 Monoclonal Antibodies: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.4 Human Insulins
5.4.1 Insulins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.4.2 Exubera: An Alternative Delivery Method for Biological Drugs
5.4.2.1 The First Inhaled Insulin
5.4.2.2 A History of Exubera: Development and Post-Marketing
5.4.3 Generex and MannKind Developing Next-Generation Oral Insulins
5.4.4 Challenges Facing Oral-lyn and Afrezza
5.5 Interferons
5.5.1 Interferons: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.6 Erythropoietin Products
5.6.1 Erythropoietins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.7 Granular-Colony Stimulating Factors (G-CSF)
5.7.1 Granular-Colony Stimulating Factors (G-CSF): Prospects, Forecast, and Implications for Drug Delivery Technologies
5.8 Recombinant Coagulation Factors
5.8.1 Recombinant Coagulation Factors: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.9 Other Therapeutic Proteins
5.9.1 Other therapeutic Proteins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.10 The Biosimilars Market in 2013
5.10.1 Biosimilars: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.11 The Vaccines Market in 2013
5.11.1 Vaccines: Market Forecast 2014-2024
5.12 The Role of Biologics in the Drug Delivery Technologies Market
6. Leading Companies in the Drug Delivery Technologies Market, 2014
6.1 Drug Delivery Technologies: A Fragmented Market
6.2 Leading Companies in Inhaled Drug Delivery Technologies
6.2.1 3M: A Global Health Information Systems Provider
6.2.1.1 3M Healthcare Revenue Analysis, 2013
6.2.1.2 3M’s Drug Delivery Technologies
6.2.1.2.1 Protein and Peptide Delivery
6.2.1.2.2 Excipient Technology for CFC-Free Inhalers
6.2.1.2.3 Actuator Technology for Metered Dose Inhalers
6.2.1.2.4 Particle Engineering Technology
6.2.2 Aradigm Corporation
6.2.2.1 AERx Drug Delivery System
6.2.2.2 Aradigm’s Partnerships
6.2.2.3 Aradigm’s Pipeline Products
6.2.3 Vectura Group
6.2.3.1 Vectura’s Technologies and Products
6.2.3.2 Vectura’s Development Pipeline
6.3 Leading Companies in Oral Drug Delivery Technologies
6.3.1 Applied Pharma Research (APR)
6.3.1.1 APR’s Technology and Product Offerings
6.3.2 Catalent Pharma
6.3.2.1 Catalent’s Drug Delivery Technologies
6.3.2.2 Catalent Revenue Analysis, 2009-2013
6.3.2.3 Catalent’s Recent Activities
6.3.3 Emisphere Technologies
6.3.3.1 Emisphere’s Eligen Technology
6.3.3.2 Emisphere Revenue Analysis, 2010-2013
6.3.3.3 Emisphere: Pipeline Products
6.3.4 Ethypharm
6.3.4.1 Ethypharm’s Drug Delivery Technologies
6.3.4.2 Ethypharm’s Currently Marketed Products
6.3.5 Glycologic
6.3.5.1 Glycologic’s Drug Delivery Technologies
6.3.5.2 Glycologic’s Pipeline Developments
6.4 Leading Companies in Injectable Drug Delivery Technologies
6.4.1 Alkermes
6.4.1.1 Alkerme’s Drug Delivery Technologies
6.4.1.2 Alkermes Revenue Analysis, 2009-2013
6.4.1.3 Alkerme’s Product Pipeline
6.4.2 Pacira Pharmaceuticals
6.4.2.1 Pacira’s Injectable Sustained–Release Technologies
6.4.2.2 Pacira Pharmaceuticals: Revenue Analysis, 2009-2013
6.5 Leading Companies in Transdermal Drug Delivery Technologies
6.5.1 Nanopass Technologies
6.5.1.1 Nanopass Drug Delivery Products
6.5.1.1.1 Anti-aging Microdermabrasion
6.5.1.1.2 Microjet Needle
6.5.2 Noven Pharmaceuticals
6.5.2.1 Noven Pharmaceuticals’ Transdermal Products
6.5.2.2 Noven’s Development Pipeline
6.6 Leading Companies for Transmucosal Drug Delivery
6.6.1 CIMA Labs
6.6.1.1 CIMA’s Transmucosal Drug Delivery Technologies
6.6.1.2 The OTS System
6.6.1.3 OraVescent Technology
6.6.2 Columbia Laboratories
6.6.2.1 Columbia Labs’ Bioadhesive Delivery Technology
6.6.2.2 Columbia Labs’ Products
6.6.2.3 Columbia Labs Revenue Analysis, 2009-2013
6.6.3 Generex Biotechnology Corporation
6.6.3.1 Generex’s Products
6.6.3.2 Generex: Revenue Analysis, 2011-2013
6.7 Leading Implantable Drug Delivery Technology Companies
6.7.1 pSivida Corporation
6.7.1.1 pSivida’s Drug Delivery Technologies
6.7.1.1.1 Durasert Technology
6.7.1.1.2 Tethadur Technology
6.7.2 pSivida Products
7. Qualitative Analysis of the Drug Delivery Technologies Market 2014-2024
7.1 SWOT Analysis of the Drug Delivery Technologies Market, 2014-2024
7.2 Strengths
7.2.1 Biosimilars: Legislations Encouraging Innovation
7.2.2 Patent Expiries and the Resulting Increase in Competition Will Favour Drug Delivery Technologies
7.2.3 Monoclonal Antibodies Will Drive Delivery Technologies
7.2.4 PEGylation Assisting Growth
7.3 Weaknesses
7.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult
7.4 Opportunities
7.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery
7.4.2 Possible New Delivery Methods for Insulin
7.4.3 Availability of Cost effective Solutions Will Stimulate Uptake of Drug Delivery Technologies
7.5 Threats
7.5.1 The Conservative Mindset of Drug Developers May Hinder Innovation in Drug Delivery
7.5.2 The Current Limit on Feasible Route of Administration for Biotech Drugs May Limit Drug Delivery Growth
7.5.3 Lifecycle Management via Protein Engineering Blurs Drug Delivery Lines
8. Expert Opinions
8.1 Interview with Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark
8.1.1 On the Current State of Drug Delivery Technologies
8.1.2 The ‘Magic Bullet’ – A Challenge for Innovation
8.1.3 Self-Assembling Protein Systems and the Use of Nanostructures for Drug Targeting
8.1.4 Technological Developments in Drug Development – Quantum Dots, Silicon Structures, and Polymeric Materials
8.1.5 On Future Challenges and Opportunities
8.2 Interview with Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
8.2.1 The Need for Novel Delivery Mechanisms Driving Growth
8.2.2 Therapeutic Areas That Are Propelling Drug Delivery Technologies
8.2.3 Drug Delivery Barriers and the Need for Targeting
8.2.4 Advancements in Drug Delivery in the Coming Years
8.2.5 Future Challenges for Drug Delivery Technologies
8.2.6 Future Opportunities for Drug Delivery Technologies
9. Conclusion
9.1 Market Overview
9.2 Commercial Drivers for Drug Delivery Technology
9.3 Transdermal Drug Delivery Technologies Set For High Growth
9.4 Biologics Will Drive Market Growth
9.5 Leading Companies in the Drug Delivery Technologies Market
9.6 Growth Concentrated in Developed Markets and in the Innovative Markets of South America and South Asia
9.7 Future Prospects for Drug Delivery Technologies
【レポート販売概要】
■ タイトル：ドラッグデリバリー技術市場（2014-2024）■ 英文：Drug Delivery Technologies Market Forecast 2014-2024
■ 発行日：2014年4月
■ 調査会社：visiongain
■ 商品コード：Visiongain-405315
■ 調査対象地域：グローバル
- 血腫：治療薬のグローバル治験動向（2014年下半期）Hematoma Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Hematoma Global Clinical Trials Review, H2, 2014" provides data on the Hematoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- ブタジエン(BD)の世界市場予測Butadiene 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about butadiene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the …
- 静電容量センサの世界市場：タッチセンサ、モーションセンサ、ポジションセンサThe capacitive sensor market is estimated to reach USD 31.79 Billion by 2022, at a CAGR of 5.4% during the forecast period. The capacitive sensor market size, in terms volume, is estimated to register a shipment of 21.14 Billion units by 2022, at a CAGR of 9.3% during the forecast period. Growing preference for capacitive touch sensors in majority of the consumer electronic products such as multi …
- 浴室付属品の世界市場：流通経路別、地域別Global Bathroom Accessories Market: About this market Technavio’s bathroom accessories market analysis considers sales from both offline and online distribution channels. Our study also finds the sales of bathroom accessories in APAC, Europe, MEA, North America, and South America. In 2019, the offline segment had a significant market share, and this trend is expected to continue over the forecast …
- 世界の飛行試験装置市場予測及び分析（2014–2020）The report provides in depth analysis of the present industry size and growth prospects during the forecast period, including highlights of key growth stimulators. The report further benchmarks the industry against key global markets and provides detailed understanding of emerging opportunities in specific areas. The report further scrutinizes the market for aviation test equipment used in militar …
- Anadarko Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Anadarko Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Anadarko Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is a …
- スマート照明（Smart Lighting）市場動向及び機会2013This report is NanoMarkets’ latest analysis of the worldwide smart lighting market. Revenues from smart lighting are expected to escalate rapidly in the coming decade, driven primarily by rising energy costs. However, NanoMarkets believes that the biggest wins in the smart lighting business will go to those who can differentiate themselves in the market by offering value-added features and interfa …
- 航空機向け情報・監視・偵察（ISR）の世界市場2017-2021：無人航空機ISR、有人航空機ISRAbout Airborne ISR Airborne intelligence, surveillance, and reconnaissance (ISR) is a crucial factor in conducting military and security operations. Defense authorities invest heavily in ISR systems to enhance national security as well as extract data from potential enemies. The airborne ISR systems collect the information from the targeted regions and pass it to the intelligence personnel, who fo …
- 真空遮断器の世界市場：回路遮断器、コンタクタ、リクローザ、負荷開閉器、タップ切換器This report estimates the vacuum interrupter market in terms of value in USD million. The overall vacuum interrupter market is expected to grow at a CAGR of 6.0% from 2015 to 2020. The market has been classified on the basis of application, end-user, and region, which has been further divided on the basis of countries. Moreover, there is an in-depth regional country analysis based on the end-user …
- グローバルにおける自動車ヘッドアップディスプレイ（HUD）市場（2014-2018）About Automotive Heads-up Display A head-up display is a device which projects a virtual image of instrumentation on the windscreen of a car which means that drivers do not need to adjust their usual viewpoint. The image detail is taken from an image source and then the image is generated in the HUD computer. The image is reflected through a relay lens assemble and is displayed on the collimator o …
- 世界の連続波発振レーザダイオード市場2015The Global Continuous Wave Laser Diode Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Continuous Wave Laser Diode industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Continuous Wave Laser Diode market analysis is provided for the international mark …
- 産業用火災安全装置の世界市場：火災報知機、消火器About Fire Safety Fire safety is a combination of practices intended to check the destructive potential of fire. Fire prevention methods include those that aim to prevent the triggering of an unrestrained fire as well as those that are employed to limit the spread and consequences of a fire after it erupts. Industrial fire prevention specializes in protecting industrial manufacturing processes, pn …
- 世界における神経血管インターベンション市場MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts Summary The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neuro …
- Friedreich Ataxia：グローバル臨床試験レビューH2, 2013Friedreich Ataxia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H2, 2013" provides data on the Friedreich Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Friedreich Ataxia. It includes an overview of the trial numbers and their recruitment s …
- Mixed Dyslipidemia（脂質異常症）：グローバル臨床試験動向（2014年上半期）Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014" provides data on the Mixed Dyslipidemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mixed Dyslipidemia. It includes an overview of the trial numbers and their recruitme …
